Rasmi R. Mishra
机构：Bilkent University
发表论文 28 篇 · 总被引 131 次 · h-index 5
代表论文
- Reactivation of cAMP Pathway by PDE4D Inhibition Represents a Novel Druggable Axis for Overcoming Tamoxifen Resistance in ER-positive Breast Cancer (2018 · Clinical Cancer Research · 被引 67)
- Comparative analysis of melanoma deregulated miRNAs in the medaka and Xiphophorus pigment cell cancer models (2014 · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · 被引 27)
- Germ cell and tumor associated piRNAs in the medaka and Xiphophorus melanoma models (2016 · BMC Genomics · 被引 14)
- Conflict of Interest Patent Info from Reactivation of cAMP Pathway by PDE4D Inhibition Represents a Novel Druggable Axis for Overcoming Tamoxifen Resistance in ER-positive Breast Cancer (2023)
- Data from Reactivation of cAMP Pathway by PDE4D Inhibition Represents a Novel Druggable Axis for Overcoming Tamoxifen Resistance in ER-positive Breast Cancer (2023)
- Supplemental Data from Reactivation of cAMP Pathway by PDE4D Inhibition Represents a Novel Druggable Axis for Overcoming Tamoxifen Resistance in ER-positive Breast Cancer (2023)